Hansoh Pharmaceutical Group Company Limited (HKG:3692)

HKG:3692 Revenue

Hansoh Pharmaceutical Group Company had revenue of 8.30B CNY in the half year ending June 30, 2026, with 27.65% growth. This brings the company's revenue in the last twelve months to 15.90B, up 20.55% year-over-year. In the year 2025, Hansoh Pharmaceutical Group Company had annual revenue of 15.03B with 22.57% growth.

• Revenue (ttm): 15.90B CNY
• Revenue Growth: +20.55%
• P/S Ratio: 11.35
• Revenue / Employee: 1.65M CNY
• Employees: 9,643
• Market Cap: 208.32B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.03B	2.77B	22.57%
Dec 31, 2024	12.26B	2.16B	21.35%
Dec 31, 2023	10.10B	721.40M	7.69%
Dec 31, 2022	9.38B	-552.73M	-5.56%
Dec 31, 2021	9.94B	1.24B	14.33%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 1, 2026

Data Sources Report a data error